Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Emcure Pharmaceuticals Ltd.

14 Jul 2025, 01:12PM

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Appointment of Mr. R.S. Vasan as President - India Business and Senior Management Personnel of the Company w.e.f. July 14, 2025.

pdf

Emcure Pharmaceuticals Ltd.

09 Jul 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection at our manufacturing facility (Oncology) located at Sanand, Ahmedabad, Gujarat, India

pdf

Emcure Pharmaceuticals Ltd.

09 Jul 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025

pdf

Emcure Pharmaceuticals Ltd.

04 Jul 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with the name "Emcure Wellness Private Limited".

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1361.60

0.47%

SAST

Emcure Pharmaceuticals Ltd - 544210 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Submission of application for seeking re-classification from the " Promoter and Promoter Group'' category to ''Public'' category

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received from the Office of the Regional Director, Western Region, Ministry of Corporate Affairs, Mumbai, on June 24, 2025.

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Disclosure Of Key Performance Indicators (Kpis) Under The SEBI (Issue …

BSE India

Disclosure of Key Performance Indicators (KPIs) under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

BSE India

Please find enclosed herewith a Press Release titled "Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary, Zuventus Healthcare Ltd."

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1361.60

0.47%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Outcome of the meeting of the Board of Directors considering requests for re-classification from the "Promoter and Promoter Group'' category to ''Public'' category

pdf